Biopreservation Market continues to witness high growth with growing focus on regenerative medicine research and technological advancements in sample storage
Biopreservation is the utilization of
antimicrobial or natural microorganisms as means of extending the shelf life
and preserving food for human consumption. The preservation of food can be for
short, as in three to forty-eight hours, or for longer periods as in two to
four months. The use of food preservation techniques and products is necessary
because there are many factors that need to be considered before putting food
on the market. Preserving food is an integral part of good food safety
practices. In terms of geographical footprint, North America seems to be
registering promising growth with consistent drug developments and advancements
in biomedical research. Furthermore, increasing demand for biopreservation
products and services for chronic diseases could potentially accelerate the
regional market growth. On the contrary, Asia Pacific seems to be exhibiting a
positive outlook due to rising number of patients suffering from chronic
diseases.
One of the primary applications of
biopreservation is in regenerative medicine research, which is an
interdisciplinary field. It deals with science and tool that can repair and
replace damaged or diseased human cells or tissues to restore normal function.
Over the years, investments in regenerative medicine research have increased.
Recently, in December 2020, Casdin Capital and BioLife Solutions Inc. invested
around US$ 4 million in GlycoNet for R&D in regenerative medicine.
Therefore, such factors can augment growth of the biopreservation
market.
Biopreservation uses microorganisms
to produce high quantities of viable organisms that can then be stored at cold
or warm temperatures for future use. Some common products of this process are
berry juice, stock, cultured pearls, cheese, whey, malt extract, yogurt, and salmon
eggs. Regardless, high costs pertaining to advanced technologies used remain
one of the major challenges in the development of the biopreservation market.
Besides, concerns regarding stability issues due to tissue injury during
freezing and thawing could pose a massive hurdle in the market development.
Furthermore, growing demand for room temperature storage technologies could
limit growth of the market.
Over the years, biobanking has
improved significantly, which refers to the process by which samples of blood
fluid or tissue are collected for research. Technological developments in terms
of storage, along with growing trend of conserving cord blood stem cells of
newborn babies have led to increased demand for biobanking. Biopreservation
plays a pivotal role in biobanking, which in turn, could potentially stimulate
growth of the biopreservation market in the near future. Recently, in October
2019, ThermoGenesis Holdings Inc. formed a joint venture with HealthBanks
Biotech (USA) Inc. to commercialize its proprietary cell processing platform
CAR-TXpres.

Comments
Post a Comment